Core Viewpoint - Pianzaihuang has established the Zhongjin Medical Fund, which has completed the private investment fund filing process, aiming to raise 1 billion yuan for investments in the healthcare sector, including traditional Chinese medicine and related industries [1][2]. Group 1: Fund Establishment and Structure - The Zhongjin Medical Fund is initiated by Pianzaihuang's wholly-owned subsidiary, Zhangzhou Pianzaihuang Investment Management Co., Ltd., in collaboration with Zhongjin Capital and other partners, with Pianzaihuang contributing 200 million yuan, representing 20% of the fund [1]. - The fund's primary focus will be on the healthcare sector, covering areas such as traditional Chinese medicine, biomedicine, medical devices, and wellness [1]. Group 2: Strategic Importance - This investment is part of the "Yuanshan Plan" initiated by the Zhangzhou government, which aims to promote the integration of medicine, healthcare, and tourism, with a total planned fund size of 5 billion yuan [2]. - Pianzaihuang has previously invested in three other funds under the "Yuanshan Plan," each contributing 200 million yuan, indicating a consistent strategy to enhance its presence in the healthcare industry [2]. Group 3: Industry Positioning - Pianzaihuang is actively pursuing a dual strategy of strengthening its core pharmaceutical business while also investing in related industries to extend its value chain and enhance its competitive edge in the healthcare ecosystem [3]. - The establishment of the Zhongjin Medical Fund is expected to further solidify Pianzaihuang's influence and competitiveness in the traditional Chinese medicine and broader healthcare sectors [3].

Core Viewpoint - The company is actively progressing with the transfer of its wastewater business assets and is in the process of obtaining necessary government approvals, with further details to be disclosed in official announcements [2]. Group 1: Asset Transfer and Financial Impact - The company is working on the transfer of its wastewater business assets, with the current status pending government approval [2]. - The potential financial benefits from the asset transfer will be clarified in future company announcements [2]. Group 2: Food Project Development - The food and pharmaceutical health industry project is currently in the preliminary design phase, with associated groundwork activities being conducted simultaneously [2]. - The timeline for the commencement of construction will be disclosed based on the progress of the project [2]. Group 3: New Subsidiary and Strategic Focus - The company has established a wholly-owned subsidiary, Yuanqi Zhenxuan Network Technology Co., Ltd., in January, focusing on the sales of taurine-related derivative products [2]. - This new subsidiary represents a significant strategic move for the company to deepen its involvement in the health industry sector [2].

Core Viewpoint - The company is establishing a new subsidiary to capitalize on opportunities in the aging society and align with the national "Healthy China 2030" initiative [1] Group 1: New Business Development - The company has set up a wholly-owned subsidiary, Hainan Gonglexiang Management Co., Ltd., to explore the health industry supply chain business [1] - A joint venture, Sanya Lexiang Gongda Supply Chain Co., Ltd., will be formed with an independent third party to officially enter the health industry supply chain [1] - The new business aims to create a comprehensive operational system covering product sales, business consulting, and talent training [1] Group 2: Market Strategy - The company plans to integrate online and offline business models to expand its health industry supply chain operations [1] - The focus will be on serving the elderly demographic with a one-stop health service branded under "Lexiang Gongda" [1] - As of the announcement date, preparations for downstream channel store recruitment and related procurement activities are underway [1] Group 3: Financial Outlook - The board anticipates that the development of this new business will open new revenue sources and have a positive impact on long-term growth [1]

禮建德集團控股有限公司 （於開曼群島註冊成立之有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 Lai Group Holding Company Limited （股份代號：8455） 自願公告 業務發展最新情況 禮建德集團控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事（「董事」）會（「董事會」）欣然 發佈本自願性公告，旨在向本公司股東及潛在投資者告知本集團一項新業務發展。 為把握老齡化社會機遇，並積極響應國家《「健康中國2030」規劃綱要》之政策指引，本集團於二零 二五年十二月十一日設立一間間接全資附屬公司海南共樂享管理有限公司（「海南共樂享」）。 本集團透過海南共樂享與中華人民共和國境內一名獨立第三方共同出資，組成合資公司三亞樂享共 達供應鏈有限公司，旨在正式開拓健康產業供應鏈業務（「新業務」）。 新業務將致力於建構一個涵蓋產品銷售、業務諮詢督導、人才培訓教育等全產業鏈營運體系。未 來，本集團計劃透過整合「線上」與「線下」 ...

Group 1 - The core theme of the forum is "Fifteen Five Start, Economic New Voyage - Reshaping Growth Paradigms, Co-creating Future Prosperity" [2] - Key speakers include prominent figures such as Sina Finance CEO Deng Qingxu and various economists and researchers discussing the development of the capital market [2][5] - The forum emphasizes the importance of collaboration among government, enterprises, capital markets, and media to activate new growth drivers through technological, institutional, and model innovations [5] Group 2 - Deng Qingxu highlights that 2025 was a year of steady progress for China's economy amidst global challenges, showcasing resilience and vitality [5] - The "Zhima AI" system developed by Sina Finance is positioned as an essential tool for investors, providing comprehensive monitoring and analysis of financial events [5] - Liu Shijin discusses the need for a balanced import-export strategy to sustain domestic consumption and suggests that the appreciation of the RMB will have long-term benefits for productivity and competitive advantage [9][7] Group 3 - Liu Shangxi emphasizes that addressing the issues faced by farmers is crucial for achieving common prosperity in China, highlighting the need for reforms to improve their social status and opportunities [12][15] - Li Daokui expresses optimism about the stock market, suggesting that the transition to a modern development-oriented government is essential for high-quality economic growth [16][18] - Li Ling discusses the importance of a health-centered development paradigm, advocating for a new health industry that could surpass the real estate sector in scale [20][22] Group 4 - Wu Xiaoqiu predicts a positive growth trend for China's capital market in 2026, attributing recent market improvements to systematic reforms and increased transparency [23][25] - He advises investors to view market downturns as opportunities for entry, emphasizing the importance of long-term trends over short-term volatility [26] - He also notes that the current influx of funds into the market must be balanced with the quality and performance of listed companies to ensure sustainable growth [30] Group 5 - He Qiang highlights the successful efforts of the China Securities Regulatory Commission in attracting long-term funds to the market, which has contributed to recent market rallies [28][29] - Liu Shuwei attributes the stock market's rise to economic cycles and improved business environments due to anti-corruption measures [31][34] - Xia Chun predicts that Hong Kong may become the second-largest international financial center, driven by the gradual appreciation of the RMB and the awakening of global investors to China's industrial achievements [36][38] Group 6 - Shen Junfeng discusses the transformation of household asset allocation, noting a shift from savings to stock investments as real estate's dominance wanes [40] - He emphasizes the importance of ETFs in long-term asset management and encourages investors to adopt a rational approach to market participation [40]

Core Viewpoint - The article emphasizes the importance of transitioning China's healthcare system from a disease-centric model to a health-centric model, highlighting the need for preventive care and a focus on overall well-being as part of the "Healthy China" national strategy [6][10]. Group 1: Healthcare System and Spending - China is recognized as the world's strongest industrialized nation, with significant progress in healthcare reform. In 2024, the total health expenditure in China was approximately 90,895.5 billion yuan, with government spending at 24.9%, social spending at 47.6%, and personal spending at 27.5%. The per capita health expenditure was 6,454.4 yuan, and the total health expenditure as a percentage of GDP fell below 7% for the first time, standing at 6.7% [4]. - The government is shifting the healthcare model to a system where hospitals and healthcare providers are incentivized to keep people healthy rather than treating them after they become ill. This involves creating a "health community" where resources are pooled to promote health and prevent disease [7]. Group 2: Challenges and Opportunities - The aging population presents significant challenges but also opportunities for a new development paradigm termed "Health+" that integrates healthcare, pharmaceuticals, green food, wellness, and elderly care into a new health industry. This industry is expected to be a lifelong necessity for individuals and could surpass the real estate sector in scale [8]. - The integration of artificial intelligence and new productive forces is seen as a competitive advantage for the nation, enabling a comprehensive health management system that spans an individual's entire life cycle [10]. Group 3: Global Contribution and Future Vision - The "Healthy China" initiative is positioned not only as a new development model for China but also as a potential original contribution to global health, leveraging China's rich agricultural civilization and wisdom in health [10]. - The article contrasts China's approach to health with that of the United States, suggesting that the challenges faced by the U.S. healthcare system present an opportunity for China to lead in global health solutions [10].

Core Insights - The "Sina Finance 2025 Conference and the 18th Golden Unicorn Forum" will be held on January 15, 2026, in Beijing, focusing on the theme of "Starting the 14th Five-Year Plan, New Economic Voyage - Reshaping Growth Paradigms, Creating Future Prosperity" [1][9] - Li Ling, a prominent figure in China's economic and health sectors, highlighted the achievements and challenges of China's healthcare system, emphasizing the need for a shift from a disease-centered approach to a health-centered paradigm [4][12] Healthcare Spending - In 2024, China's total health expenditure is estimated at 90,895.5 billion yuan, with government spending accounting for 24.9%, social spending for 47.6%, and personal spending for 27.5% [1][9] - The per capita health expenditure is 6,454.4 yuan, and the total health expenditure as a percentage of GDP is 6.7%, marking a significant decline below 7% for the first time [1][9] Challenges and Opportunities - The aging population presents significant challenges, necessitating a focus on disease prevention rather than treating aging as a disease [4][12] - The "Healthy China" national strategy prioritizes health as a key indicator of socialist modernization, advocating for a preventive approach to health [4][12] Systemic Changes in Healthcare - The government is promoting a systemic approach to healthcare, integrating county, township, and village services into a cohesive "health community" model, moving away from hospitals competing for patient revenue [5][13] - The "Sanming Model" aims to incentivize hospitals and doctors to manage patients' health proactively, with a nationwide rollout planned within four years [5][13] Emerging Health Industry - The integration of healthcare, pharmaceuticals, green food, wellness, and elderly care is expected to create a new "big health" industry, which could surpass the real estate sector in scale [5][13] - This industry is seen as a lifelong necessity for individuals, with potential benefits extending beyond China to serve global health needs [5][13] Future Health Management - The envisioned future health model includes a personal health code system, supported by AI for continuous health management throughout an individual's life [6][14] - The "Healthy China" and "Smart Health" initiatives are positioned as new development models that will contribute significantly to global health, leveraging China's historical wisdom and modern technological advancements [6][14]

Core Viewpoint - The "Sina Finance 2025 Conference and the 18th Golden Unicorn Forum" emphasizes the theme of reshaping growth paradigms and creating future prosperity, highlighting the importance of health in China's modernization strategy [1][9]. Group 1: Healthcare Spending and Trends - In 2024, China's total health expenditure is estimated at 90,895.5 billion yuan, with government spending at 24.9%, social spending at 47.6%, and personal spending at 27.5% [1][9]. - The per capita health expenditure is 6,454.4 yuan, and the health expenditure as a percentage of GDP has dropped to 6.7%, marking a significant decline below 7% for the first time [1][9]. Group 2: Challenges and Strategic Shifts - The primary challenge facing China is population aging, necessitating a shift from a disease treatment focus to a health-centered approach, promoting disease prevention [4][12]. - The "Healthy China" national strategy prioritizes health as a key indicator of socialist modernization, requiring collaboration among government, society, and individuals to implement a preventive health model [4][12]. Group 3: Systemic Changes in Healthcare - The government is promoting a systemic approach to healthcare, integrating county, township, and village services into a cohesive "health community," moving away from a profit-driven model based on patient volume [5][13]. - The "Sanming Model" aims to incentivize hospitals and doctors to manage patients' health effectively, with a goal of nationwide implementation within four years [5][13]. Group 4: Opportunities in the Health Industry - The aging population presents opportunities for a new "health+" development paradigm, integrating healthcare, pharmaceuticals, green food, wellness, and elderly care into a large health industry [5][13]. - This emerging health industry is expected to be a lifelong necessity for individuals, with potential market size surpassing that of real estate, serving both Chinese citizens and the global population [5][13]. Group 5: Future Health Management - The envisioned future health model includes a personal health code system, utilizing AI for continuous health management throughout an individual's life, aiming to reduce disease incidence and promote longevity [6][14]. - The integration of traditional wisdom with modern technology is seen as a unique contribution from China to global health, especially in light of challenges faced by developed nations like the U.S. [6][14].

Group 1 - The core theme of the "2025 Sina Finance Annual Conference and the 18th Golden Unicorn Forum" is "Fifteen Five Opening, Economic New Voyage - Reshaping Growth Paradigms, Co-creating Future Prosperity" [1][12] - Li Ling, a prominent figure in the economic committee, emphasized that China is currently the world's strongest industrialized nation and has made significant progress in healthcare reform [3][14] - The total national health expenditure for 2024 is preliminarily estimated at 90,895.5 billion yuan, with government health spending at 24.9%, social health spending at 47.6%, and personal health spending at 27.5% [3][14] Group 2 - The aging population presents a significant challenge, necessitating a shift from treating diseases to preventing them [6][17] - The "Healthy China" national strategy is prioritized as it signifies the modernization of socialism, focusing on health rather than illness [7][18] - The government is integrating health into all policies, addressing various factors affecting health, including lifestyle, environment, and healthcare systems [7][18] Group 3 - The healthcare system is transitioning to a more integrated model, promoting a "health community" approach where hospitals work collaboratively rather than independently [7][19] - The "Sanming Model" is being promoted nationwide within four years, incentivizing healthcare providers to focus on disease prevention [7][19] - The aging population also presents opportunities for a new "health+" development paradigm, merging healthcare, wellness, and technology into a large health industry [8][19] Group 4 - The future health model includes a personal health code system managed by AI, ensuring comprehensive health management throughout an individual's life [10][21] - The "Healthy China" initiative is seen as a new development model and a significant contribution to global health, leveraging China's historical wisdom and modern technology [10][21] - The challenges faced by the U.S. in healthcare present an opportunity for China to lead in health solutions, integrating various advantages to contribute to global health [10][22]

Core Viewpoint - The company forecasts a significant increase in net profit for 2025, with expected growth rates of 272.14%-330.62% for net profit attributable to shareholders and 519.13%-643.41% for net profit after deducting non-recurring items, indicating a strong performance recovery driven by product improvements and market conditions [1] Group 1: Financial Performance - The company anticipates a net profit range of 350-405 million yuan for 2025, with a midpoint of 378 million yuan, representing a year-on-year increase of 301.4%, surpassing market expectations [1] - The sales volume of key products, such as chili red and chili extract, is expected to grow by approximately 27% and 65% year-on-year, respectively, contributing to the overall profit increase [1] - The company has built strategic inventories of 7,177 tons of chili red, 2,314 tons of chili extract, and 2,705 tons of lutein, which are expected to enhance performance release [1] Group 2: Market Dynamics - The company is positioned to benefit from the FDA's policy banning synthetic colorants, which is projected to create a new market scale of at least 3 billion USD for natural colorants by the end of 2026, thereby boosting industry prosperity [1] - The main products are currently priced at the lower end of their price range, with significant potential for price improvement in the future [1] Group 3: Strategic Outlook - As a leader in the plant extraction industry, the company is expected to leverage its advanced extraction technology and low-cost industrial production capabilities to replicate its successful multi-product development model efficiently [2] - The company aims to expand its market share in health products and traditional Chinese medicine extraction, positioning itself for rapid growth in the high-demand health industry [2] - Profit forecasts for 2025-2027 indicate net profits of 376 million, 453 million, and 554 million yuan, with corresponding year-on-year growth rates of 299%, 21%, and 22% [2]